An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people who are at risk for schizophrenia, reports a study from investigators at Columbia University Medical Center (CUMC) published ...
Apr 18, 2013
0
0
Spinal muscular atrophy is a debilitating neuromuscular disease that in its most severe form is the leading genetic cause of infant death. By experimenting with an ALS drug in two very different animal models, researchers ...
Apr 9, 2013
0
0
(Medical Xpress)—Clumps of α-synuclein protein in nerve cells are hallmarks of many degenerative brain diseases, most notably Parkinson's disease.
Mar 28, 2013
0
0
A single concussion may cause lasting structural damage to the brain, according to a new study published online in the journal Radiology.
Mar 12, 2013
0
0
A revolutionary technology has the ability to detect and diagnose Alzheimer's disease with unprecedented accuracy. The computerized technique known as SNIPE analyzes magnetic resonance imaging (MRI) scans to capture patterns ...
Feb 6, 2013
0
0
All patients with Alzheimer's disease (AD) lose brain cells, which leads to a shrinking, or atrophy, of the brain. But the pattern of gray matter loss is significantly different in men and women, according to a study presented ...
Nov 26, 2012
0
0
(HealthDay)—In older adults, physical activity is associated with less brain atrophy and white matter lesion (WML) load, according to a study published in the Oct. 23 issue of Neurology.
Oct 24, 2012
0
0
An inexpensive, five-minute eye scan can accurately assess the amount of brain damage in people with the debilitating autoimmune disorder multiple sclerosis (MS), and offer clues about how quickly the disease is progressing, ...
Oct 17, 2012
1
0
A research team from Germany has found that optimal benefit and functional improvement for ischemic stroke results when human umbilical cord blood mononuclear cells (hUCB MNCs) are transplanted into rat stroke models within ...
Oct 1, 2012
0
0
The medication fingolimod reduced inflammatory lesion activity and reduced brain volume loss in patients with multiple sclerosis who participated in a two-year placebo-controlled clinical trial and were assessed by magnetic ...
Jul 2, 2012
0
0
